Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Reliefband®, Wearable Technology, Provides Relief to Those with Chronic Motion Sickness

Reliefband Technologies
Posted on: 13 Nov 17

Whether it’s the nauseating effects of motion sickness from travel, vertigo or virtual reality, Reliefband® wearable technology is enabling chronic motion sickness sufferers to feel confident to live their lives in full motion. With 30 million chronic sufferers of motion sickness in the United States, Reliefband Technologies is the leader in providing neuro-stimulation for the drug-free treatment of nausea.

Genetics can be responsible for as much as 57% of people’s tendency to get motion sickness1. However, the nausea, retching and vomiting caused from motion sickness can come from any type of movement and almost anyone traveling can be at risk during certain conditions. Cars, trains, boats, cruise ships, planes, amusement rides, vertigo, and virtual reality when gaming, cause a sensory conflict. This occurs when one’s vision fools their brain into believing that they’re actually moving, when, in fact, they’re not moving at all, or vice versa. Reliefband technology controls that feeling of nausea within minutes.

FDA-cleared, clinically proven and used in hospitals for years, the wearable Reliefband technology uses the body’s own neural pathways to naturally control nausea. Delivering gentle pulses to the median nerve at the P6 pressure point located on the underside of the wrist, the pulses send signals to the nausea control center of the brain to resolve the conflict between what we see and what we feel. This groundbreaking therapy works as well as a leading prescription medication without side effects such as drowsiness or constipation.

“Since 2014, the Company has demonstrated the viability of our technology in the Over-The-Counter healthcare market by significantly growing unit and dollar sales,” according to Nick Spring, President and CEO of Reliefband Technologies. “Reliefband Technologies has primarily focused on direct-to-consumer online distribution, and recently, due to uplifting demand has selectively increased distribution in specialty retail environments.”

As an experienced and accomplished healthcare CEO and entrepreneur with a track record of developing startup healthcare business, Nick Spring believes there is tremendous opportunity for growth with this technology. “Given the rapid increase in wearable technology and consumers desiring to manage their health without medications, new approaches like ours are on the forefront of helping those in need.”

For more information please visit

1. Reavley, Caroline M.; Golding, John F.; Cherkas, Lynn F.; Spector, Tim D.; MacGregor, Alex J. “Genetic Influences on Motion Sickness Susceptibility in Adult Women: A Classical Twin Study.” Aviation, Space, and Environmental Medicine, Volume 77, Number 11, November 2006, pp. 1148-1152(5)

View source version on

Business Wire

Last updated on: 13/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.